1. Home
  2. VERA vs HURN Comparison

VERA vs HURN Comparison

Compare VERA & HURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • HURN
  • Stock Information
  • Founded
  • VERA 2016
  • HURN 2002
  • Country
  • VERA United States
  • HURN United States
  • Employees
  • VERA N/A
  • HURN N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • HURN Professional Services
  • Sector
  • VERA Health Care
  • HURN Consumer Discretionary
  • Exchange
  • VERA Nasdaq
  • HURN Nasdaq
  • Market Cap
  • VERA 2.0B
  • HURN 2.6B
  • IPO Year
  • VERA 2021
  • HURN 2004
  • Fundamental
  • Price
  • VERA $24.00
  • HURN $139.61
  • Analyst Decision
  • VERA Buy
  • HURN Strong Buy
  • Analyst Count
  • VERA 8
  • HURN 4
  • Target Price
  • VERA $64.63
  • HURN $170.75
  • AVG Volume (30 Days)
  • VERA 2.3M
  • HURN 187.3K
  • Earning Date
  • VERA 08-07-2025
  • HURN 07-29-2025
  • Dividend Yield
  • VERA N/A
  • HURN N/A
  • EPS Growth
  • VERA N/A
  • HURN 92.74
  • EPS
  • VERA N/A
  • HURN 6.67
  • Revenue
  • VERA N/A
  • HURN $1,525,814,000.00
  • Revenue This Year
  • VERA N/A
  • HURN $11.50
  • Revenue Next Year
  • VERA N/A
  • HURN $7.48
  • P/E Ratio
  • VERA N/A
  • HURN $20.95
  • Revenue Growth
  • VERA N/A
  • HURN 8.98
  • 52 Week Low
  • VERA $18.53
  • HURN $96.45
  • 52 Week High
  • VERA $51.61
  • HURN $155.00
  • Technical
  • Relative Strength Index (RSI)
  • VERA 54.33
  • HURN 50.92
  • Support Level
  • VERA $22.76
  • HURN $135.66
  • Resistance Level
  • VERA $23.97
  • HURN $140.77
  • Average True Range (ATR)
  • VERA 1.21
  • HURN 3.19
  • MACD
  • VERA 0.15
  • HURN 0.76
  • Stochastic Oscillator
  • VERA 73.63
  • HURN 81.39

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About HURN Huron Consulting Group Inc.

Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.

Share on Social Networks: